Global concerns rise over possibility Canada backs out of AIDS fight funding

International concern is growing in medical and development circles that the Trudeau government is about to step back from its much-publicized global leadership on eradicating AIDS, tuberculosis and malaria.

In 2016, Trudeau announced with fanfare that Canada was contributing $804 million to the Global Fund, a 24-per-cent increase to the international organization that aims to curb the three afflictions that are now widely seen as preventable with the proper amount of medical and financial support.

“Other countries are starting to move in that direction,” said Dr. Julio Montaner, the director of the British Columbia Centre for Excellence in HIV/AIDS.

“My bottom line is we want Canada to be not just counted but playing a leadership role, making an early pledge and in doing so, providing an example to the rest of the world.”

Montaner’s research led to the medical breakthrough that controlled and reduced the spread of HIV-AIDS in the late 1990s: the “triple cocktail” of antiretroviral drugs that has been credited with reducing mortality across the globe.

The approach has been replicated worldwide, and is now the cornerstone of the work of the Global Fund, he said.

“I am very hopeful that Prime Minister Trudeau will make an executive decision in short order to do the right thing,” Montaner said.

Scroll to Top

The BC-CfE Laboratory is streamlining reporting processes for certain tests in order to simplify distribution and record-keeping, and to ensure completeness of results. Beginning September 2, 2025, results for the ‘Resistance Analysis of HIV-1 Protease and Reverse Transcriptase’ (Protease-RT) and ‘HIV-1 Integrase Resistance Genotype’ tests will be combined into a single ‘HIV-1 Resistance Genotype Report’.
For more details and example reports, please click on the button below